{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:59:00Z","timestamp":1792432740236,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejps.2020.105589","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T11:28:41Z","timestamp":1602329321000},"page":"105589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The effects of P-glycoprotein inhibitor zosuquidar on the sex and time-dependent pharmacokinetics of parenterally administered talinolol in mice"],"prefix":"10.1016","volume":"156","author":[{"given":"Zeliha","family":"Pala Kara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Ozturk Civelek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narin","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Okyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2020.105589_bib0001","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","article-title":"Intraperitoneal Route of Drug Administration: should it Be Used in Experimental Animal Studies?","volume":"37","author":"Al Shoyaib","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105589_bib0002","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/07420520500180231","article-title":"Daily rhythms of P-glycoprotein expression in mice","volume":"22","author":"Ando","year":"2005","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.ejps.2020.105589_bib0003","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.85.12.4350","article-title":"The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus","volume":"85","author":"Arceci","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2020.105589_bib0004","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.toxlet.2004.12.008","article-title":"Does inhibition of P-glycoprotein lead to drug-drug interactions?","volume":"156","author":"Balayssac","year":"2005","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejps.2020.105589_bib0005","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/bph.15017","article-title":"Timing in drug absorption and disposition: the past, present, and future of chronopharmacokinetics","volume":"177","author":"Bicker","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105589_bib0006","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/jps.21044","article-title":"Biological rhythms: a neglected factor of variability in pharmacokinetic studies","volume":"97","author":"Bruguerolle","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105589_bib0007","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-3-642-14541-4_6","article-title":"P-glycoprotein: tissue distribution, substrates, and functional consequences of genetic variations","volume":"201","author":"Cascorbi","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105589_bib0008","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/0929867013373903","article-title":"Reversal of multidrug resistance by the P-Glycoprotein modulator, LY335979, from the bench to the clinic","volume":"8","author":"Dantzig","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2020.105589_bib0009","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0022-3565(24)34974-2","article-title":"Selectivity of the multidrug resistance modulator, LY335979, for P-Glycoprotein and effect on cytochrome P-450 activities","volume":"290","author":"Dantzig","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2020.105589_bib0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev-physiol-021909-135821","article-title":"The mammalian circadian timing system: organization and coordination of central and peripheral clocks","volume":"72","author":"Dibner","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejps.2020.105589_bib0011","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/00498250802687657","article-title":"Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers","volume":"39","author":"Fan","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2020.105589_bib0012","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/pros.10354","article-title":"P-Glycoprotein \u0131ncreases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cells","volume":"59","author":"Fedoruk","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.ejps.2020.105589_bib0013","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0169-409X(02)00064-9","article-title":"The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans","volume":"54","author":"Fromm","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105589_bib0014","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0006-2952(01)00599-8","article-title":"Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells","volume":"61","author":"Green","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105589_bib0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0928-0987(00)00195-0","article-title":"Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats","volume":"12","author":"Hanafy","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105589_bib0016","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1152\/ajplegacy.1975.229.5.1427","article-title":"Circadian rhythm of biliary excretion and its control mechanisms in rats with chronic biliary drainage","volume":"229","author":"Ho","year":"1975","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejps.2020.105589_bib0017","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00280-003-0720-y","article-title":"The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice","volume":"53","author":"Kemper","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105589_bib0018","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1023\/B:PHAM.0000033017.52484.81","article-title":"P-glycoprotein (P-gp\/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro","volume":"21","author":"Kim","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105589_bib0019","first-page":"477","article-title":"Pharmacokinetics and tissue transport of intraperitoneal chemotherapy","volume":"27","author":"Lagast","year":"2018","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.ejps.2020.105589_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.pharmtox.48.113006.094626","article-title":"Circadian Timing in Cancer Treatments","volume":"50","author":"L\u00e9vi","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2020.105589_bib0021","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.pharmtox.47.120505.105208","article-title":"Circadian Rhythms: mechanisms and Therapeutic Implications","volume":"47","author":"Levi","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2020.105589_bib0022","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics: clinical implications","volume":"42","author":"Lin","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2020.105589_bib0023","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s40265-017-0729-x","article-title":"Clinical implications of P-glycoprotein modulation in drug\u2013drug interactions","volume":"77","author":"Lund","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2020.105589_bib0024","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/dmd.108.020859","article-title":"Closing the gaps: a full scan of the intestinal expression of P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats","volume":"36","author":"MacLean","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2020.105589_bib0025","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1124\/dmd.113.051680","article-title":"In vivo assessment of the impact of efflux transporter on oral drug absorption using portal vein-cannulated rats","volume":"41","author":"Matsuda","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2020.105589_bib0026","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2008.07.073","article-title":"Circadian clock-controlled intestinal expression of the multidrug-resistance gene mdr1a in mice","volume":"135","author":"Murakami","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2020.105589_bib0027","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1349-7006.2006.00300.x","article-title":"Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells","volume":"97","author":"Mutoh","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejps.2020.105589_bib0028","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0021-9673(97)00966-7","article-title":"Determination of drugs in biological fluids by high-performance liquid chromatography with on-line sample processing","volume":"797","author":"Oertel","year":"1998","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.ejps.2020.105589_bib0029","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0378-4347(94)00301-7","article-title":"Elucidation of the structure of talinolol metabolites in man determination of talinolol and hydroxylated talinolol metabolites in urine and analysis of talinolol in serum","volume":"660","author":"Oertel","year":"1994","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.ejps.2020.105589_bib0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.addr.2010.01.006","article-title":"Chronotherapeutic strategy: rhythm monitoring, manipulation and disruption","volume":"62","author":"Ohdo","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105589_bib0031","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2133\/dmpk.22.3","article-title":"Chronopharmacology Focused on Biological Clock","volume":"22","author":"Ohdo","year":"2007","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2020.105589_bib0032","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/07420528.2012.668996","article-title":"Circadian Variations in Exsorptive Transport: in Situ Intestinal Perfusion Data and In Vivo Relevance","volume":"29","author":"Okyar","year":"2012","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.ejps.2020.105589_bib0033","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1038\/s41598-019-46977-0","article-title":"Sex-, feeding-, and circadian time-dependency of P-glycoprotein expression and activity - implications for mechanistic pharmacokinetics modeling","volume":"9","author":"Okyar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2020.105589_bib0034","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-3-642-14541-4_11","article-title":"In vivo probes of drug transport: commonly used probe drugs to assess function of intestinal P-glycoprotein (ABCB1) in humans","volume":"201","author":"Oswald","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105589_bib0035","first-page":"29","article-title":"Pharmacokinetics of talinolol is modified by barnidipine: implication of P-glycoprotein modulation","volume":"72","author":"Ozturk","year":"2017","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejps.2020.105589_bib0036","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4155\/bio.09.162","article-title":"Validated HPLC method for quantitative determination of talinolol in rat plasma and application to a preclinical pharmacokinetic study","volume":"2","author":"Pathak","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ejps.2020.105589_bib0037","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/07420529409057246","article-title":"Circadian rhythms of renal hemodynamics in unanesthetized, unrestrained rats","volume":"11","author":"Pons","year":"1994","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.ejps.2020.105589_bib0038","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1081\/CBI-200026466","article-title":"Chronobiological study of the pharmacological response of rats to combination ketamine-midazolam","volume":"21","author":"Rebuelto","year":"2004","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.ejps.2020.105589_bib0039","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105589_bib0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.10792","article-title":"Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979","volume":"103","author":"Shepard","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejps.2020.105589_bib0041","first-page":"16","article-title":"P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound","volume":"36","author":"Spahn-Langguth","year":"1998","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2020.105589_bib0042","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1134\/S0006297908050118","article-title":"Transport proteins of the ABC family and multidrug resistance of tumor cells","volume":"73","author":"Stavrovskaya","year":"2008","journal-title":"Biochem. (Mosc.)"},{"key":"10.1016\/j.ejps.2020.105589_bib0043","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1254\/jphs.08100SC","article-title":"Diurnal rhythmicity in the transcription of jejunal drug transporters","volume":"108","author":"Stearns","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2020.105589_bib0044","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.lfs.2006.01.024","article-title":"Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats","volume":"79","author":"Suzuki","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.ejps.2020.105589_bib0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pharmthera.2005.06.005","article-title":"Expression and function of efflux drug transporters in the intestine","volume":"109","author":"Takano","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2020.105589_bib0046","first-page":"170","article-title":"The biliary elimination of the selective beta-receptor blocking drug talinolol in man","volume":"27","author":"Terhaag","year":"1989","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.ejps.2020.105589_bib0047","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/bdd.2510160505","article-title":"Disposition and bioavailability of the \u03b21\u2010adrenoceptor antagonist talinolol in man","volume":"16","author":"Trausch","year":"1995","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2020.105589_bib0048","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s11095-005-2588-5","article-title":"The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen","volume":"22","author":"Weitschies","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105589_bib0049","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1023\/A:1016029601311","article-title":"Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo","volume":"13","author":"Wetterich","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2020.105589_bib0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/dmd.108.024174","article-title":"Circadian Expression Profiles of Drug-Processing Genes and Transcription Factors in Mouse Liver","volume":"37","author":"Zhang","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2020.105589_bib0051","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/00498250701867889","article-title":"Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition","volume":"38","author":"Zhou","year":"2008","journal-title":"Xenobiotica"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720303778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720303778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:54:22Z","timestamp":1760529262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720303778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":51,"alternative-id":["S0928098720303778"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105589","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of P-glycoprotein inhibitor zosuquidar on the sex and time-dependent pharmacokinetics of parenterally administered talinolol in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105589"}}